EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Pyoderma gangrenosum complicating Crohns disease with infliximab



Treatment of Pyoderma gangrenosum complicating Crohns disease with infliximab



Gastroenterology 120(5 Supplement 1): A 621, April




(PDF emailed within 1 workday: $29.90)

Accession: 035980587

Download citation: RISBibTeXText



Related references

Treatment of peristomal pyoderma gangrenosum associated with Crohns disease with infliximab. American Journal of Gastroenterology 98(9 Supplement): S175, September, 2003

Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Digestive Diseases and Sciences 49(9): 1454-1457, 2004

Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease. Acta Dermatovenerologica Alpina, Pannonica, et Adriatica 15(4): 173-177, 2007

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. American Journal of Gastroenterology 98(8): 1821-1826, 2003

Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease. Journal of Dermatology 39(6): 576-578, 2012

Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum. Scandinavian Journal of Gastroenterology 37(7): 863-865, July, 2002

Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Romanian Journal of Gastroenterology 14(4): 401-403, 2006

Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease. European Journal of Dermatology 13(3): 258-260, 2003

Infliximab for treatment of pyoderma gangrenosum. Netherlands Journal of Medicine 73(7): 357-357, 2016

Infliximab as a treatment for recalcitrant pyoderma gangrenosum. Clinical and Experimental Dermatology 29(2): 196-197, 2004

Successful treatment of IBD-associated pyoderma gangrenosum with infliximab. Gastroenterology 122(4 Suppl 1): A 616, April, 2002

Intestinal strictures complicating initially successful Infliximab treatment for luminal Crohns disease. American Journal of Gastroenterology 95(9): 2503, September, 2000

Crohns disease epidermolysis bullosa acquisita and pyoderma gangrenosum. British Journal of Dermatology Supplement 105(19): 52-54, 1981

A case of metastatic Crohns disease mimicking pyoderma gangrenosum. Journal of Pathology 181(SUPPL ): 61A, 1997